BlueLinx (BXC) Q3 2026 earnings summary

Executive summary

• Q3 net sales rose 8.5% YoY to $812.6m; gross profit increased 21.0% to $131.0m and gross margin expanded to 16.1% from 14.4%.

• GAAP net loss was $0.6m, or $0.07 per diluted share; adjusted net income was $5.5m and adjusted diluted EPS was $0.68.

• Adjusted EBITDA rose 42% to $31.7m; quarter-end available liquidity was $688.9m.

Financial highlights

• Q3 operating income was $11.9m versus $10.0m YoY; SG&A rose 18.6% to $105.9m, mainly due to Disdero, freight, fuel and employee-related costs.

• Adjusted net income increased 50% YoY to $5.5m; adjusted diluted EPS rose 51% to $0.68 from $0.45.

• Adjusted EBITDA margin was 3.9% versus 3.0%; excluding import-duty items, adjusted EBITDA was $29.5m versus $24.6m.

• YTD net sales rose 5.3% to $2.36bn and gross profit increased 14.2% to $387.1m; net income declined to $4.3m from $8.8m.

Outlook and guidance

• Q4 specialty gross margin expected at 17.5%–18.5%; structural gross margin expected at 9.0%–10.0%.

• Q4 average daily sales volumes expected slightly below Q3 2026 and Q4 2025.

• Transformation design and implementation work expected to continue through 2028; strategic priorities include specialty growth, productivity and disciplined investment.